Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Depreciation & Amortization (IS)EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Outstanding Shares Outstanding

LifeStance Health (LFST) Shares Issued (2021)

LifeStance Health (LFST) has disclosed Shares Issued for 1 consecutive years, with $554.2 million as the latest value for Q2 2021.

Quarterly Shares Issued changed N/A to $554.2 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $554.2 million through Dec 2022, changed 0.0% year-over-year, with the annual reading at $548.9 million for FY2021, N/A changed from the prior year.
Shares Issued for Q2 2021 was $554.2 million at LifeStance Health.
The five-year high for Shares Issued was $554.2 million in Q2 2021, with the low at $554.2 million in Q2 2021.